These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 38302621

  • 1. Role of prior intratympanic gentamicin and corticosteroids therapy on speech understanding in patients with Menière's disease after cochlear implantation.
    Thangavelu K, Gillhausen F, Weiß RM, Mueller-Mazzotta J, Stuck BA, Reimann K.
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3483-3490. PubMed ID: 38302621
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intratympanic gentamicin injection for refractory ménière's disease (MD) has potential effect in preventing contralateral MD occurrence.
    Wu Y, Zhou Y, Yu J, Song Z, Dai C, Wang J.
    Acta Otolaryngol; 2021 Jul; 141(7):657-662. PubMed ID: 33950779
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
    Gabra N, Saliba I.
    Otolaryngol Head Neck Surg; 2013 Apr; 148(4):642-7. PubMed ID: 23314159
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Management of intractable Ménière's disease after intratympanic injection of gentamicin.
    Rah YC, Han JJ, Park J, Choi BY, Koo JW.
    Laryngoscope; 2015 Apr; 125(4):972-8. PubMed ID: 25363447
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of intratympanic gentamicin for treatment of Ménière's disease on lower frequency hearing.
    Sam G, Chung DW, van der Hoeven R, Verweij S, Becker M.
    Int J Clin Pharm; 2016 Aug; 38(4):780-3. PubMed ID: 27073077
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endolymphatic sac surgery versus intratympanic gentamicin for the treatment of intractable Ménière's disease: a retrospective review with survey.
    Paradis J, Hu A, Parnes LS.
    Otol Neurotol; 2013 Oct; 34(8):1434-7. PubMed ID: 23846192
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intratympanic gentamicin for Meniere's disease: short- and long-term follow-up of two regimens of treatment.
    Casani AP, Cerchiai N, Navari E, Dallan I, Piaggi P, Sellari-Franceschini S.
    Otolaryngol Head Neck Surg; 2014 May; 150(5):847-52. PubMed ID: 24477826
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N, Boleas MS, Martin E.
    Audiol Neurootol; 2005 May; 10(2):69-78. PubMed ID: 15650298
    [Abstract] [Full Text] [Related]

  • 19. On-Demand and Low Dose Intratympanic Gentamicin for Meniere's Disease: A Customized Approach.
    Celis-Aguilar E, Castro-Bórquez KM, Obeso-Pereda A, Escobar-Aispuro L, Burgos-Paez A, Alarid-Coronel JM, Verdiales-Lugo S, León-Leyva IC, Trejo-González CF, López-Favela LM, Martínez-Román L.
    Otol Neurotol; 2020 Apr; 41(4):504-510. PubMed ID: 32176139
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.